CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats
Pharmacological Reports · 2023
DOI: 10.1007/s43440-023-00446-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Reports, 2023. Verfasst von Mohammad Zafar Imam und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia Campus, Brisbane, QLD, 4072, Australia. Hauptthemen laut MEDLINE: Constipation, Morphine, Receptors, Opioid, delta, Respiratory Insufficiency. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council Large Linkage Grant, National Natural Science Foundation of China, UQ Graduate School Scholarship.
Themen: Depression
Abstract (Originalsprache)
Background
Strong opioid analgesics such as morphine alleviate moderate to severe acute nociceptive pain (e.g. post-surgical or post-trauma pain) as well as chronic cancer pain. However, they evoke many adverse effects and so there is an unmet need for opioid analgesics with improved tolerability. Recently, a prominent hypothesis has been that opioid-related adverse effects are mediated by β-arrestin2 recruitment at the µ-opioid (MOP) receptor and this stimulated research on discovery of G-protein biassed opioid analgesics. In other efforts, opioids with MOP agonist and δ-opioid (DOP) receptor antagonist profiles are promising for reducing side effects c.f. morphine. Herein, we report on the in vivo pharmacology of a novel opioid peptide (CYX-5) that is a G-protein biassed MOP receptor agonist, DOP receptor antagonist and kappa opioid (KOP) receptor agonist.
Methods
Male Sprague–Dawley received intracerebroventricular bolus doses of CYX-5 (3, 10, 20 nmol), morphine (100 nmol) or vehicle, and antinociception (tail flick) was assessed relative to constipation (charcoal meal and castor oil-induced diarrhoea tests) and respiratory depression (whole body plethysmography).
Results
CYX-5 evoked naloxone-sensitive, moderate antinociception, at the highest dose tested. Although CYX-5 did not inhibit gastrointestinal motility, it reduced stool output markedly in the castor oil-induced diarrhoea test. In contrast to morphine that evoked respiratory depression, CYX-5 increased tidal volume, thereby stimulating respiration.
Conclusion
Despite its lack of recruitment of β-arrestin2 at MOP, DOP and KOP receptors, CYX-5 evoked constipation, implicating a mechanism other than β-arrestin2 recruitment at MOP, DOP and KOP receptors, mediating constipation evoked by CYX-5 and potentially other opioid ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia Campus, Brisbane, QLD, 4072, Australia.
- School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China.
- School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China. l_tingyou@njmu.edu.au.
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia Campus, Brisbane, QLD, 4072, Australia. maree.smith@uq.edu.au.
Förderung
- Australian Research Council Large Linkage Grant
- National Natural Science Foundation of China
- UQ Graduate School Scholarship
- Research Training Program Scholarship
- Queensland Government Smart State Research Facilities Programme
- Australian Government National Collaborative Research Infrastructure Strategy 9NCRIS) program
- Therapeutic Innovation Australia
Zitieren
APA
Imam, M. Z., Kuo, A., Ghassabian, S., Cai, Y., Qin, Y., Li, T., & Smith, M. T. (2023). CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats. Pharmacological Reports. https://doi.org/10.1007/s43440-023-00446-8
Vancouver
Imam MZ, Kuo A, Ghassabian S, Cai Y, Qin Y, Li T, et al. CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats. Pharmacological Reports. 2023. doi:10.1007/s43440-023-00446-8
BibTeX
@article{Imam2023,
author = {Imam, Mohammad Zafar and Kuo, Andy and Ghassabian, Sussan and Cai, Yunxin and Qin, Yajuan and Li, Tingyou and Smith, Maree T},
title = {CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats},
journal = {Pharmacological Reports},
year = {2023},
doi = {10.1007/s43440-023-00446-8}
}
EUVIMED